There was a death within one of the clinical trials that was related to cardiovascular dysfunction
For example, a provider might prescribe a 10-week protocol aligned with a tendon injury rehabilitation program, with no immediate plan to cycle back on
Evidence claims are graded by study type
For now, DHK-Cu remains an intriguing piece of the puzzleone that may yet prove more significant than its current obscurity suggests
Another drug, activated protein C, reduces BBB breakdown and leakage in stroke model rodents and has anti-inflammatory effects, neuroprotective effects, and blocks hemorrhage after brain ischemia [126, 127]
The optimal therapeutic approach may depend on the specific clinical indication, individual patient factors, availability of different treatment options, and the regulatory framework within the practicing jurisdiction